Kura Oncology KURA Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's net income?
- Kura Oncology (KURA) reported net income of -$73.33M in Q1 2026.
- How has Kura Oncology's net income changed year-over-year?
- Kura Oncology's net income decreased by 27.7% year-over-year, from -$57.43M to -$73.33M.
- What is the long-term trend for Kura Oncology's net income?
- Over 4 years (2021 to 2025), Kura Oncology's net income has grown at a 20.9% compound annual growth rate (CAGR), from -$130.47M to -$278.67M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.